Literature DB >> 7356512

Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone.

S S Hecht, C B Chen, T Ohmori, D Hoffmann.   

Abstract

The tobacco-specific carcinogens, N'-nitrosonornicotine (NNN) and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK), were tested for carcinogenicity in F344 rats. Each nitrosamine in trioctanoin was administered by s.c. injection to 12 male and 12 female rats over a period of 20 weeks. The total dose of each nitrosamine was 3.4 mmol. The experiment was terminated after 12 months. NNK induced nasal cavity tumors in 83% of the males and in 83% of the females, liver tumors in 83% of the males and in 100% of the females, and lung tumors in 67% of the males and in 67% of the females. NNN induced nasal cavity tumors in 92% of the males and in 75% of the females. Only one liver tumor and no lung tumors were observed in the NNN-treated rats. These results indicate that, in the F344 rat, NNK is a more powerful carcinogen than is NNN.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356512

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Formation of genotoxic products from N-nitrosoheptamethyleneimine (NHMI), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N'-nitrosonornicotine (NNN) by isolated rabbit lung cells.

Authors:  J E Dahl; R Becher; M Låg; H M Schuller; E Dybing
Journal:  Cell Biol Toxicol       Date:  1990-10       Impact factor: 6.691

Review 2.  Drug metabolism in the nasal mucosa.

Authors:  M A Sarkar
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

3.  Quantitation of pyridyloxobutyl-DNA adducts in tissues of rats treated chronically with (R)- or (S)-N'-nitrosonornicotine (NNN) in a carcinogenicity study.

Authors:  Lijiao Zhao; Silvia Balbo; Mingyao Wang; Pramod Upadhyaya; Samir S Khariwala; Peter W Villalta; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2013-09-18       Impact factor: 3.739

4.  Mass spectrometry based approach to study the kinetics of O6-alkylguanine DNA alkyltransferase-mediated repair of O6-pyridyloxobutyl-2'-deoxyguanosine adducts in DNA.

Authors:  Delshanee Kotandeniya; Dan Murphy; Uthpala Seneviratne; Rebecca Guza; Anthony Pegg; Sreenivas Kanugula; Natalia Tretyakova
Journal:  Chem Res Toxicol       Date:  2011-09-29       Impact factor: 3.739

Review 5.  Context Matters: Contribution of Specific DNA Adducts to the Genotoxic Properties of the Tobacco-Specific Nitrosamine NNK.

Authors:  Lisa A Peterson
Journal:  Chem Res Toxicol       Date:  2016-12-08       Impact factor: 3.739

6.  Tobacco-Specific Nitrosamines in the Tobacco and Mainstream Smoke of U.S. Commercial Cigarettes.

Authors:  Selvin H Edwards; Lana M Rossiter; Kenneth M Taylor; Matthew R Holman; Liqin Zhang; Yan S Ding; Clifford H Watson
Journal:  Chem Res Toxicol       Date:  2016-12-21       Impact factor: 3.739

7.  It is time to regulate carcinogenic tobacco-specific nitrosamines in cigarette tobacco.

Authors:  Stephen S Hecht
Journal:  Cancer Prev Res (Phila)       Date:  2014-05-07

8.  Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.

Authors:  Gang Chen; Shaman Luo; Shannon Kozlovich; Philip Lazarus
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-09       Impact factor: 4.254

9.  Formation, repair, and genotoxic properties of bulky DNA adducts formed from tobacco-specific nitrosamines.

Authors:  Lisa A Peterson
Journal:  J Nucleic Acids       Date:  2010-09-05

10.  Analysis of pyridyloxobutyl and pyridylhydroxybutyl DNA adducts in extrahepatic tissues of F344 rats treated chronically with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.

Authors:  Siyi Zhang; Mingyao Wang; Peter W Villalta; Bruce R Lindgren; Pramod Upadhyaya; Yanbin Lao; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2009-05       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.